State Street’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$43.2M Buy
1,380,460
+1,074,840
+352% +$33.6M ﹤0.01% 1752
2025
Q1
$10.3M Buy
305,620
+16,898
+6% +$567K ﹤0.01% 2512
2024
Q4
$11.3M Buy
288,722
+9,209
+3% +$361K ﹤0.01% 2554
2024
Q3
$11M Buy
279,513
+32,701
+13% +$1.29M ﹤0.01% 2544
2024
Q2
$9.62M Buy
246,812
+4,172
+2% +$163K ﹤0.01% 2582
2024
Q1
$10.4M Buy
242,640
+15,600
+7% +$672K ﹤0.01% 2562
2023
Q4
$10.5M Buy
227,040
+14,670
+7% +$676K ﹤0.01% 2567
2023
Q3
$7.25M Sell
212,370
-180
-0.1% -$6.15K ﹤0.01% 2750
2023
Q2
$8.18M Buy
212,550
+5,094
+2% +$196K ﹤0.01% 2751
2023
Q1
$7.42M Buy
207,456
+10,020
+5% +$359K ﹤0.01% 2817
2022
Q4
$7.78M Buy
197,436
+27,065
+16% +$1.07M ﹤0.01% 2841
2022
Q3
$6.15M Sell
170,371
-26,850
-14% -$969K ﹤0.01% 2958
2022
Q2
$6M Buy
197,221
+25,234
+15% +$768K ﹤0.01% 3007
2022
Q1
$5.26M Buy
171,987
+10,738
+7% +$328K ﹤0.01% 3155
2021
Q4
$5.04M Buy
161,249
+13,802
+9% +$431K ﹤0.01% 3237
2021
Q3
$2.25M Buy
147,447
+16,852
+13% +$258K ﹤0.01% 3576
2021
Q2
$2.43M Buy
130,595
+32,507
+33% +$605K ﹤0.01% 3512
2021
Q1
$1.76M Buy
98,088
+4,702
+5% +$84.2K ﹤0.01% 3487
2020
Q4
$1.44M Buy
93,386
+3,839
+4% +$59K ﹤0.01% 3480
2020
Q3
$991K Buy
89,547
+2,883
+3% +$31.9K ﹤0.01% 3440
2020
Q2
$1.09M Buy
86,664
+67,686
+357% +$849K ﹤0.01% 3400
2020
Q1
$215K Sell
18,978
-1,382
-7% -$15.7K ﹤0.01% 3560
2019
Q4
$267K Sell
20,360
-304
-1% -$3.99K ﹤0.01% 3602
2019
Q3
$186K Hold
20,664
﹤0.01% 3617
2019
Q2
$204K Hold
20,664
﹤0.01% 3613
2019
Q1
$210K Sell
20,664
-624
-3% -$6.34K ﹤0.01% 3570
2018
Q4
$134K Buy
21,288
+1,788
+9% +$11.3K ﹤0.01% 3613
2018
Q3
$257K Buy
+19,500
New +$257K ﹤0.01% 3568